TOP TIERMARKET NEWSWIRE
News & sentiment

ARRIVENT BIOPHARMA I (AVBP) — News & AI sentiment

ARRIVENT BIOPHARMA I (AVBP) news roundup. 4 stories in the past week, 25 over 30 days. Average 30-day sentiment is 53.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 43.5/100
30d stories
25
avg sentiment 53.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

AVBP news in the last 24 hours, 7 days, 30 days and 90 days

How much AVBP coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAVBP storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days443.5/100AVBP headlines →
Last 30 days2553.5/100AVBP headlines →
Last 90 days6143.8/100AVBP headlines →

Latest stories on AVBP

4d ago
Guggenheim lowers ArriVent BioPharma stock price target to $28
Investing.com Analyst Ratings34 · bearishanalyst
4d ago
4d ago
5d ago
Nov 10
Nov 10
ArriVent BioPharma GAAP EPS of -$0.81
Seeking Alpha52 · neutralearnings
Nov 10
Nov 9
Nov 9
Nov 9
Nov 9
Nov 9
Oct 27
Oct 27
Oct 26
Oct 26
Oct 26
At a glance: stocks gapping up premarket
Seeking Alpha63 · neutralgeneral
Oct 26
Oct 26
Oct 25
Oct 25
Oct 25
Oct 23
Oct 23
Oct 23
Open AVBP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →